TGFB1 and pulmonary fibrosis: The serum concentrations of PTX-2 are decreased in patients with pulmonary fibrosis, while the injection of PRM-151 suppresses pulmonary fibrosis development in bleomycin-induced and TGF-β-expressing mice models of pulmonary fibrosis [280].